Andrew Smith

Researchers from the Ecole Polytechnique Federale de Lausanne report having developed a fast and accurate method for determining exactly which milk proteins produce allergic reactions in specific patients.

Researchers in Australia have released the results of a study showing that dropping testosterone levels in older men could potentially put them at risk when taking care of themselves in their later years.

Preliminary research suggests that optogenetics could eventually replace electric shocks in the treatment of atrial fibrillation.

Researchers analyzed records from more than 25,000 Medicare beneficiaries and found no evidence that testosterone replacement therapy increases the risk of heart attack among older men.

A pair of randomized controlled studies have both found that continuous monitoring of patients after cryptogenic strokes can detect several times as many cases of atrial fibrillation as conventional monitoring.

Analysis of emergency department cases indicates that anaphylaxis severity increases with age and other health problems, but preparations can reduce the danger to patients.

The US Food and Drug Administration recently announced it will require the makers of testosterone replacement therapies to add general warnings about venous blood clots to product labels.

Phase II trial data suggest that a fixed-dose combination of ranolazine and low-dose dronedarone may significantly reduce disease burden among patients with atrial fibrillation.

A taskforce from the European Academy of Allergy and Clinical Immunology has reviewed all the published research and formulated a new set of comprehensive guidelines for diagnosing and treating anaphylaxis.

New research financed by Medtronic Inc. suggests that implantable cardiac resynchronization therapy devices governed by its new algorithms may reduce atrial fibrillation-related complications in patients who have experienced heart failure.

This marks the first testosterone nasal gel for replacement therapy in adult males approved by the FDA for conditions associated with a deficiency or absence of endogenous testosterone.

Data from a large cohort of Swedish men suggest that regular vigorous exercise starting around age 30 may increase the risk of atrial fibrillation, particularly among those who stop exercising later in life.

A new study finds that regular exercise can boost the effect of testosterone replacement therapy among men who suffer from late-onset hypogonadism.

New research has reached the unexpected conclusion that non-steroidal anti-inflammatory drugs (NSAIDs) may rank among the top causes of drug-induced anaphylaxis.

Study shows bariatric surgery can not only help obese patients lose weight, but also reduce their risk of developing atrial fibrillation.

Comparatively few patients treated for anaphylaxis in the emergency department are prescribed adrenaline autoinjectors, and many who do receive them either do not know how to properly use the device or fail to carry it with them at all times.

Just weeks after Australian researchers published data suggesting that testosterone replacement therapy does not ameliorate type 2 diabetes among hypogonadal men, a team of American researchers has unveiled a second study that suggests just the opposite.

Are most people who show mild sensitivity to bee venom a sting away from developing systemic allergies and suffering anaphylaxis? New research suggests the answer is no, but they are in danger of serious reactions at the sting site.

Findings from a pair of ongoing studies into the effects of testosterone replacement therapy indicate unexpected significant improvements for obese patients.

A new study indicates that treating hyperlipidemia, glucose intolerance, high blood pressure, sleep apnea, and other risk factors associated with atrial fibrillation can dramatically reduce the burden of the disease or eliminate it entirely.

Research from the Mayo Clinic suggests that an order set designed to standardize the treatment of anaphylaxis in emergency departments may lead to improved guideline adherence and better treatment outcomes.

Research presented at the 2014 annual meeting of the American Association of Clinical Endocrinologists indicates that testosterone replacement therapy may reduce the risk of cardiovascular events, contradicting two widely reported studies.

Total number of hospitalizations increased by more than 23%, while associated treatment costs rose but mortality declined.

New research may help doctors predict when patients who have suffered one attack of anaphylaxis will undergo a second attack without any additional exposure to the original trigger.

Study of obese men with low testosterone and type 2 diabetes showed no benefits from treatment with intramuscular testosterone undecanote in glucose metabolism or visceral adiposity.

Patients treated with too much or too little warfarin for atrial fibrillation (AF) are significantly more likely to develop dementia than patients who maintain proper medication levels.

New research shows that food allergies may have increased more far more quickly among black children than among American children as a whole, leading to increased risk of anaphylaxis.

Research from Chile suggests that low levels of free testosterone - rather than high ones - indicate that an apparently low-risk case of prostate cancer will require treatment.

Analysis of American hospital data found that the incidence of strokes associated with atrial fibrillation (AF) shot up 42% in just 7 years.

Research from North Carolina's biggest universities that identified new ways to bind polyphenol-rich foods with peanut flour may one day help patients with severe food allergies develop increased tolerance without risking anaphylaxis.